GeekWire July 6, 2020
Todd Bishop

Accolade’s share price is up 38% since its initial public offering on Thursday, marking a successful debut for the health benefits management company at a time of unprecedented uncertainty in the industry, the economy and the broader world.

“The environment today is clearly very unique,” said Accolade CEO Rajeev “Raj” Singh in an interview with GeekWire shortly after the company’s shares began trading on the Nasdaq. “We filed to go public in February of this year. The pandemic hit, and the market went straight through the floor in March, and yet somehow it’s rebounded. Even with its rebound, though, the world that we live in as a healthcare technology company has been disrupted in so many ways.”

From Concur to...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Healthcare System, Insurance, Interview / Q&A, Investments, Public Health / COVID, Technology, Trends
Hospice Handoffs May Lower Odds of Medicare Denials
What would happen if we eliminated medical debt?
Major health insurance companies are nearing too big to fail status
STAT+: Medicare official says breakthrough device reimbursement rule coming in early summer
Advising on longevity

Share This Article